If the FDA loses, the agency could decide to release fewer guidance documents, which give companies insight into its thinking ...
Insurers tout value based care, we round up hospital finances, and regulators have an eye on vertical integration.
Former FDA commissioner Scott Gottlieb is raising concerns with Senate Republicans about the president-elect’s selection of ...
The H5N1 bird flu outbreak in the U.S. has so far been shockingly mild. Researchers have some theories as to why.
Novartis is paying $1 billion upfront in a licensing deal for an experimental Huntington’s disease treatment from PTC ...
Perkins is the director of Health Policy Strategy at the Center for Advancing Health Policy through Research (CAHPR) at the ...
There's growing interest in radiopharmaceuticals. But a "significant talent shortage" may threaten the field's rise.
Today's health news includes theories about the mildness of the H5N1 outbreak and the best and worst restaurant policies on ...
The breast cancer drug Enhertu will be added to China’s national health insurance scheme beginning in the new year — despite ...
Some of the 20 largest U.S. restaurant chains have received failing grades when it comes to adopting policies for restricting ...
Former FDA Commissioner Scott Gottlieb, who served in the first Trump administration, is raising concerns with Republicans ...
Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.